Form Bio Co. Ltd. (377220) - Net Assets
Based on the latest financial reports, Form Bio Co. Ltd. (377220) has net assets worth ₩36.61 Billion KRW (≈ $24.81 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩75.59 Billion ≈ $51.22 Million USD) and total liabilities (₩38.97 Billion ≈ $26.41 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Form Bio Co. Ltd. asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩36.61 Billion |
| % of Total Assets | 48.44% |
| Annual Growth Rate | N/A |
| 5-Year Change | 107.71% |
| 10-Year Change | N/A |
| Growth Volatility | 118.64 |
Form Bio Co. Ltd. - Net Assets Trend (2019–2024)
This chart illustrates how Form Bio Co. Ltd.'s net assets have evolved over time, based on quarterly financial data. Also explore balance sheet size of Form Bio Co. Ltd. for the complete picture of this company's asset base.
Annual Net Assets for Form Bio Co. Ltd. (2019–2024)
The table below shows the annual net assets of Form Bio Co. Ltd. from 2019 to 2024. For live valuation and market cap data, see Form Bio Co. Ltd. market cap and net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩49.10 Billion ≈ $33.28 Million |
-34.68% |
| 2023-12-31 | ₩75.17 Billion ≈ $50.94 Million |
-14.54% |
| 2022-12-31 | ₩87.96 Billion ≈ $59.61 Million |
+4.18% |
| 2021-12-31 | ₩84.43 Billion ≈ $57.22 Million |
+257.14% |
| 2020-12-31 | ₩23.64 Billion ≈ $16.02 Million |
+331.53% |
| 2019-12-31 | ₩-10.21 Billion ≈ $-6.92 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Form Bio Co. Ltd.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 2034554857000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | ₩52.02 Billion | 103.54% |
| Total Equity | ₩50.24 Billion | 100.00% |
Form Bio Co. Ltd. Competitors by Market Cap
The table below lists competitors of Form Bio Co. Ltd. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
NamSys Inc
V:CTZ
|
$24.35 Million |
|
Plan Optik AG
F:P4O
|
$24.36 Million |
|
Yung Zip Chemical Ind Co Ltd
TWO:4102
|
$24.36 Million |
|
Asia Technology Co Ltd
KQ:050860
|
$24.37 Million |
|
Vmoto Ltd
AU:VMT
|
$24.34 Million |
|
Prologue
PA:ALPRG
|
$24.33 Million |
|
Minim Inc
NASDAQ:MINM
|
$24.33 Million |
|
Blueberry NFT CO.LTD
KQ:044480
|
$24.33 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Form Bio Co. Ltd.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 76,644,745,650 to 50,243,452,900, a change of -26,401,292,750 (-34.4%).
- Net loss of 25,288,086,890 reduced equity.
- Other factors decreased equity by 1,113,205,860.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩-25.29 Billion | -50.33% |
| Other Changes | ₩-1.11 Billion | -2.22% |
| Total Change | ₩- | -34.45% |
Book Value vs Market Value Analysis
This analysis compares Form Bio Co. Ltd.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.72x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | ₩-738.01 | ₩1269.00 | x |
| 2020-12-31 | ₩1708.72 | ₩1269.00 | x |
| 2021-12-31 | ₩5964.50 | ₩1269.00 | x |
| 2022-12-31 | ₩6213.73 | ₩1269.00 | x |
| 2023-12-31 | ₩2707.34 | ₩1269.00 | x |
| 2024-12-31 | ₩1774.76 | ₩1269.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Form Bio Co. Ltd. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -50.33%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -37.64%
- • Asset Turnover: 0.83x
- • Equity Multiplier: 1.62x
- Recent ROE (-50.33%) is below the historical average (-13.46%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 0.00% | -33.98% | 2.55x | 0.00x | ₩-20.00 Billion |
| 2020 | -33.05% | -7.23% | 2.40x | 1.90x | ₩-10.18 Billion |
| 2021 | 13.36% | 8.35% | 1.40x | 1.14x | ₩2.84 Billion |
| 2022 | 3.68% | 3.26% | 1.06x | 1.07x | ₩-5.56 Billion |
| 2023 | -14.45% | -16.60% | 0.69x | 1.27x | ₩-18.74 Billion |
| 2024 | -50.33% | -37.64% | 0.83x | 1.62x | ₩-30.31 Billion |
Industry Comparison
This section compares Form Bio Co. Ltd.'s net assets metrics with peer companies in the Packaged Foods industry.
Industry Context
- Industry: Packaged Foods
- Average net assets among peers: $576,846,886,459
- Average return on equity (ROE) among peers: 7.22%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Form Bio Co. Ltd. (377220) | ₩36.61 Billion | 0.00% | 1.06x | $24.35 Million |
| Daehan Flour Mills Co Ltd (001130) | $603.49 Billion | 5.29% | 0.49x | $174.98 Million |
| Daesang Corp (001680) | $367.29 Billion | 1.41% | 1.72x | $486.05 Million |
| Daesang Corp Preference Shares (001685) | $1.02 Trillion | 10.49% | 1.35x | $15.68 Million |
| Korea Ind (002140) | $32.94 Billion | 8.67% | 1.46x | $47.32 Million |
| Choheung (002600) | $120.39 Billion | 9.38% | 0.40x | $59.77 Million |
| Sam Yang Foods (003230) | $162.54 Billion | -1.94% | 0.82x | $5.05 Billion |
| Daejoo Inc (003310) | $83.51 Billion | 9.96% | 0.33x | $82.87 Million |
| Harim Holdings Co. Ltd (003380) | $2.72 Trillion | 8.97% | 3.88x | $864.77 Million |
| Hansung Ent (003680) | $23.53 Billion | 19.94% | 3.72x | $19.75 Million |
| Namyang Dairy (003920) | $631.79 Billion | 0.04% | 0.15x | $209.00 Million |
About Form Bio Co. Ltd.
From Bio Co.,Ltd manufactures and sells health related products in South Korea. It offers health functional food, health beauty, and living health products. The company also provides cosmetic products under the Mastina and HYCL brands. In addition, it operates an online platform to retail its products. The company was founded in 2006 and is headquartered in Suwon-si, South Korea.